Related Experiment Videos
Prophylactic fluconazole and Candida krusei infections
The New England Journal of Medicine
|March 26, 1992
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2002
Non-myeloablative hematopoietic stem cell transplantation.
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2001
Nonmyeloablative hematopoietic stem cell transplantation: transplantation for the 21st century.
Frontiers in bioscience : a journal and virtual library·2001
Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2001
Nonmyeloablative hematopoietic cell transplantation. Replacing high-dose cytotoxic therapy by the graft-versus-tumor effect.
Annals of the New York Academy of Sciences·2001
Fibromyalgia.
The New England journal of medicine·2026
Health Care-Associated Infections in U.S. Hospitals, 2023 versus 2015.
The New England journal of medicine·2026
Extended Dual Antiplatelet Therapy for Multivessel Coronary Artery Disease.
The New England journal of medicine·2026
Continuous or Fixed-Duration Maintenance Therapy in Multiple Myeloma.
The New England journal of medicine·2026
Andes Virus - A Clinical Review.
The New England journal of medicine·2026
Platelet-Activating Anti-Platelet Factor 4 Disorders.
The New England journal of medicine·2026
Outcomes of nucleos(t)ide analogue discontinuation following finite xalnesiran-based therapies in chronic hepatitis B.
JHEP reports : innovation in hepatology·2026
Syringeable hyaluronic acid-based hydrogel co-loaded with Cisplatin and MSA-2 for enhanced ovarian cancer chemoimmunotherapy.
Biomedical materials (Bristol, England)·2026
Caffeine in the Context of Sorafenib Chemotherapy: Insights From Experimental Hepatocarcinogenesis.
Journal of biochemical and molecular toxicology·2026